m6A-Related lncRNA Signature Is Involved in Immunosuppression and Predicts the Patient Prognosis of the Age-Associated Ovarian Cancer
Background. Epithelial ovarian cancers are age-associated diseases, usually diagnosed at an advanced stage. lncRNA has been discovered to interplay with N6-methyladenosine (m6A), working in tandem to promote cancer progression and worsening patient outcomes. This study is aimed at investigating the...
Saved in:
| Main Authors: | Ming Li, Liang Zhang, Miaoxiao Feng, Xiao Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2022/3258400 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of a Hypoxia-Angiogenesis lncRNA Signature Participating in Immunosuppression in Gastric Cancer
by: Zicheng Wang, et al.
Published: (2022-01-01) -
Involvement of lncRNA in cancer diagnosis and prognosis and clinical implications
by: Chainsee Saini, et al.
Published: (2025-01-01) -
Development of a m6A- and ferroptosis-related LncRNA signature for forecasting prognosis and treatment response in cervical cancer
by: Kaiting Wen, et al.
Published: (2025-03-01) -
mRNA-lncRNA gene expression signature in HPV-associated neoplasia and cervical cancer
by: E. D. Kulaeva, et al.
Published: (2024-05-01) -
Cell-in-cell associated lncRNA signature predicts prognosis and immunotherapy response in gastric cancer
by: Junzuo Lin, et al.
Published: (2025-07-01)